News and Announcements
Q&A with Joe Barber, CEO of STEM Venture MOTUM Simulation
- Published May 28, 2021 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Sidney Macdessi sits down with Joe Barber, CEO of MOTUM Simulation. MOTUM is tackling the niche market of simulators, taking the industry by storm with its immense cost – efficiency and practicality.
About MOTUM Simulation Pty Ltd
MOTUM Simulation is a Melbourne-based motion simulation company that has designed, developed and commercialised the world’s most cost-effective Six Degrees of Freedom motion simulation system. The patented motion base enables the system to provide simulation of land, sea and air vehicles with a very high degree of fidelity that to date has been only available on simulation platforms that cost at least 5 times more than the price offered by MOTUM.
Since its inception in 2016, MOTUM has been working with customers in the motor sport and the defence sector to validate the product’s veracity in these very rigorous environments.
MOTUM is now in a very strong position to expand its market reach, both in Australia and overseas, into the entertainment, driver education and aviation simulator markets, whilst developing further its penetration into the motor racing and defence sectors.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
